Drawing for THERAHEMP

USPTO serial 88282891

THERAHEMP

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SMIGA, HOWARD
Law office
TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with THERAHEMP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Perla M. Kuhn

PERLA M. KUHN FOX ROTHSCHILD LLP997 LENOX DRIVE, BUILDING 3PRINCETON PIKE CORPORATE CENTERLAWRENCEVILLE, NJ 08648-2311

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for use in the pharmaceutical industry; chemical additives for use in the manufacture of pharmaceuticals; botanical extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; botanical extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; plant extracts, active substances and active chemical ingredients for use in the pharmaceutical industry; plant extracts, active substances and active chemical ingredients for use in the manufacture of medicines for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; chemicals for use in the cosmetics and food industry; botanical extracts for use in the cosmetics and food industry; botanical extracts for use in the manufacture of cosmetics and dietary supplements; plant extracts, active substances and active chemical ingredients for use in the cosmetics and food industry; plant extracts, active substances and active chemical ingredients for use in the manufacture of cosmetics and dietary supplementsACTIVE—
005Pharmaceuticals based on botanical and plant extracts; pharmaceuticals based on botanical and plant extracts for use in the treatment of skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disorders; dietary supplements based on botanical and plant extracts; dietary supplements based on botanical and plant extracts in the form of pharmaceuticals for treating skin diseases, neuropathic pain, cancer pain, autoimmune diseases, anorexia, AIDS, psychiatric disorders, neurovegetative disorders and metabolic disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Apr 2, 2020MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 2, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 16, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2019DOCKASSIGNED TO EXAMINER—
Feb 27, 2019DOCKASSIGNED TO EXAMINER—
Feb 22, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 2, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance